Conmed (NASDAQ: CNMD) reported Q1 EPS of $0.53, $0.09 better than the analyst estimate of $0.44. Revenue for the quarter came in at $202.1 million versus the consensus estimate of $196.4 million.

GUIDANCE:

Conmed raises FY2018 EPS to $2.15-$2.20, versus the consensus of $2.14.

For earnings history and earnings-related data on Conmed (CNMD) click here.